Imaging study of using positron emission tomography for the effect of nootropics on the athletic performance
Not Applicable
- Conditions
- healthy adults
- Registration Number
- JPRN-UMIN000006960
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
- with past or current history of psychiatric illness - with past or current history of serious medical illness and/or brain organic diseases - subject who is contraindicated for the use of MRI - with past or current history ofsevere liver disease, kidney disease, heart disease, allergy, or severe drug allergy - subject who are judged as not suitable for participation in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect of the nootropics on the monoaminergic neuron system quantified by positron emission tomography
- Secondary Outcome Measures
Name Time Method blod and/or urine concentration, MRI